中国听力康复与人工耳蜗进展综述
本文综述中国听力损失(HL)的流行病学、新生儿听力筛查、遗传病因学及人工耳蜗(CI)项目的实施情况。文章指出中国政府通过中国残疾人联合会等项目资助听力障碍的预防、治疗与康复,新生儿听力筛查与听觉康复项目在政府支持下快速扩展,CI项目亦显著增长。分享中国听觉康复与CI项目经验可为其他发展中国家提供参考。
要点
- 中国听障人群的预防、治疗与康复获政府项目资助。
- 新生儿听力筛查与听觉康复项目在政府支持下快速扩展。
- 中国CI项目显著增长,并面临诸多挑战与障碍。
核心结论
- 中国在听力康复与人工耳蜗项目上取得显著进展,其经验可为其他发展中国家提供借鉴。
研究设计与样本
- 综述,讨论中国HL的CI项目实施,并呈现流行病学、新生儿听力筛查与遗传病因学等数据。
主要发现
- 中国听障人群的预防、治疗与康复获政府项目(如中国残疾人联合会)资助。
- 新生儿听力筛查与听觉康复项目在政府支持下快速扩展。
- 中国CI项目显著增长,同时面临诸多挑战与障碍。
关键数值与推荐
- 听力损失(HL)是常见的感觉障碍,具有显著经济与社会影响。
- 中国人口占世界近20%,政府通过中国残疾人联合会等项目资助听力障碍的预防、治疗与康复。
临床怎么用
- 分享中国听觉康复与CI项目经验,可为其他发展中国家发展医疗基础设施以满足听障人群需求提供参考。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Hearing loss (HL) is a common sensory impairment in humans, with significant economic and social impacts. With nearly 20% of the world's population, China has focused on economic development and health awareness to improve the care for its hearing-impaired population. Recently, the Chinese government has initiated national programs such as the China Disabled Persons Federation to fund prevention, treatment, and rehabilitation of hearing impairment. Newborn hearing screening and auditory rehabilitation programs in China have expanded exponentially with government support. While facing many challenges and overcoming obstacles, cochlear implantation (CI) programs in China have also experienced considerable growth. This review discusses the implementation of CI programs for HL in China and presents current HL data including epidemiology, newborn hearing screening, and determination of genetic etiologies. Sharing the experience in Chinese auditory rehabilitation and CI programs will shine a light on the developmental pathway of healthcare infrastructure to meet emerging needs of the hearing-impaired population in other developing countries.
引用
- Li JN, Chen S, Zhai L, et al. The Advances in Hearing Rehabilitation and Cochlear Implants in China. Ear Hear. 2017. PMID: 28471842. doi:10.1097/AUD.0000000000000441
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。